Press Release

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

ConcertAI & NeoGenomics Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative AI Solutions at 2024 JP Morgan Conference

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

NeoGenomics to Appeal Ruling

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients